To show the superiority of epinastine 0.05 % ophthalmic solution ( epinastine ) to placebo ophthalmic solution ( placebo ) and noninferiority to olopatadine 0.1 % ophthalmic solution ( olopatadine ) for cedar pollen antigen-induced ocular itching and conjunctival hyperemia .